Michael Andersson

17.3k citations
125 papers · 13.7k · 4 hit papers · h-index 42

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology

Papers in

    • HER2/EGFR in Cancer Research 21
    • Cancer Treatment and Pharmacology 12
    • Breast Cancer Treatment Studies 18

Michael Andersson

124 papers receiving 13.0k citations

Michael Andersson's Hit Papers

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up 2021 · 261 citations
2610+9+18Years since publication10002.0k3.0k4.0k

Peers

Michael Andersson
Comparison fields: 5 of 142
  • Cancer Research 3.3k
  • Oncology 5.8k
  • Radiology, Nuclear Medicine and Imaging 2.2k
  • Pathology and Forensic Medicine 1.5k
  • Pulmonary and Respiratory Medicine 2.1k
Replace Bernard Asselain with:
Bernard Asselain France
Constance Cirrincione United States
David John Dodwell United Kingdom
Elżbieta Senkus Poland
ANTHONY D. ELIAS United States
George E. Pentheroudakis Greece
Pamela B. Mangu United States
Heinz Schmidberger Germany
Alan Horwich United Kingdom
Samuel Hellmän United States
Michael Andersson relative to Bernard Asselain France Bernard Asselain's profile →
Citations per field
00.5×2×2.6×
Bernard Asselain · 1×
Citations per year

Countries citing papers authored by Michael Andersson

Since Specialization
Citations

This map shows the geographic impact of Michael Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Andersson more than expected).

Fields of papers citing papers by Michael Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Andersson. The network helps show where Michael Andersson may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Andersson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Andersson Line = papers co-authored together Michael Andersson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Hit paper breakdown →
20054136
2
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
Hit paper breakdown →
19991324
3
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
Hit paper breakdown →
2005638
4 2009567
5 2003539
6 2002464
7 2013400
8 1997389
9 1999300
10 2000292
11 2007283
12 2007281
13
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up
Hit paper breakdown →
2021261
14 2010242
15 2003174
16 2011152
17 2007150
18 2009136
19 2008124
20 2017123

About Michael Andersson

Michael Andersson is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Urology, having authored 125 papers that have together received 13.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (21 papers), Breast Cancer Treatment Studies (18 papers), Cancer Treatment and Pharmacology (12 papers), Radiation Dose and Imaging (10 papers), Effects of Radiation Exposure (6 papers), Multiple and Secondary Primary Cancers (5 papers), Urinary Bladder and Prostate Research (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Cancer Research (3.3k citations), Oncology (5.8k citations), Radiology, Nuclear Medicine and Imaging (2.2k citations), Pathology and Forensic Medicine (1.5k citations) and Pulmonary and Respiratory Medicine (2.1k citations). Michael Andersson has collaborated with scholars based in Denmark, Sweden and United States. Frequent co-authors include Hans Henrik Storm, Eero Pukkala, Lois B. Travis, Charles F. Lynch, Eric J. Holowaty, Mary Krystyna Gospodarowicz, Maj‐Britt Jensen, Claus Kamby, Per Hall and John D. Boice. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, JNCI Journal of the National Cancer Institute, Acta Oncologica and Radiation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact